RxDoctor Payments Data

Leigh Gebhardt, APRN

Psychiatric/Mental Health · Lexington, KYNPI 1346720968

Payments from drug & device makers

$1,604in general payments, 2019–2025

Across 50 payments — averaging $32.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$509
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$307
  • Teva Pharmaceuticals USA, Inc.$177
  • Alkermes, Inc.$173
  • Neurocrine Biosciences, Inc.$125
  • Lundbeck LLC$89
  • plus $225 from 8 others

What the payments were for

  • Food & beverage$1,604100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,604 in reported general payments places this provider in the 65th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$16,076
Medicare patients
42
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lurasidone Hcl20$6,867
Aripiprazole66$2,317
Buspirone Hcl165$2,028
Desvenlafaxine Succinate ErDesvenlafaxine Succinate28$1,492
Duloxetine Hcl59$828
Fluoxetine Hcl71$530
Ziprasidone Hcl17$526
Lamotrigine73$490
Quetiapine Fumarate ErQuetiapine Fumarate11$483
Prazosin Hcl31$466
Quetiapine Fumarate28$407
Venlafaxine Hcl ErVenlafaxine Hcl21$353
Trazodone Hcl80$330
Lithium Carbonate ErLithium Carbonate21$311
Mirtazapine25$305

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →